In the high-profile prosecution of Elizabeth Holmes and Ramesh “Sunny” Balwani, the role and admissibility of Fraud Investigation Expert Witness testimony became a focal point in the Ninth Circuit’s review of their convictions for securities fraud and related offenses. The case, stemming from the collapse of Theranos, Inc., addressed not only the substance of the fraud allegations but also the critical evidentiary standards governing expert witness testimony in complex financial trials. The appellate decision is found at USA v. Holmes, No. 23-1167 (9th Cir. 2025).
Background and Parties
Elizabeth Holmes, founder and CEO of Theranos, and Ramesh “Sunny” Balwani, the company’s president, were charged with multiple counts of wire fraud and conspiracy to commit wire fraud. The government alleged that Holmes and Balwani made false statements to investors and patients about the capabilities and reliability of Theranos’s blood-testing technology, resulting in hundreds of millions of dollars in investments and significant public harm.


